Cano Health's Q2 Miss and Restructuring: Shares Take a Hit
- August 11th, 2023
- 369 views
Cano Health, Inc. (NYSE: CANO) reported a Q2 2023 loss of $(0.51) per share, which fell short of the consensus estimate loss of $(0.12). The company's quarterly sales were also below expectations, totaling $766.70 million while analysts projected $828.43 million for the period.
Cano Health also unveiled plans to sell itself, accompanied by the decision to discontinue operations in California, New Mexico, Illinois by fall 2023, and Puerto Rico by the end of the year. The company is implementing a comprehensive operational restructuring plan aimed at enhancing efficiency and reducing costs. As part of this restructuring, Cano Health is projected to downsize its workforce by about 700 employees, which constitutes 17% of its total workforce, in the third quarter of 2023.
$CANO was trading at $0.86 in pre-market, reflecting a significant decline of $0.66 or 43.42%
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Tags
Post Your Comments
Want To Find Some News?
Recent Posts
-
Key Earnings Ahead for Netflix, Fastenal, and U.S. Bancorp
January 18th, 2026Louisville Thunder Appoints Veteran Coach Mike Reed to Lead Program
January 15th, 2026FDA Approves First Treatment for Children With Menkes Disease
January 13th, 2026January 13th, 2026Wall Street Eyes Bank of America, Wells Fargo, Citi Ahead of Earnings
January 11th, 2026
Member Login